Pmd105 - Evaluating the Cost-Effectiveness of Screening for the Genetic Risk of Thrombosis During the Recommendation of Combined Hormonal Contraception for First-Time Users in Switzerland

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.1554
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Hormonal Contraception and Thrombosis

Fertility and Sterility
GynecologyReproductive MedicineObstetrics
2016English

Venous Thrombosis in Users of Non-Oral Hormonal Contraception: Follow-Up Study, Denmark 2001-10

British Medical Journal
Medicine
2012English

Risk Prediction of Developing Venous Thrombosis in Combined Oral Contraceptive Users

PLoS ONE
Multidisciplinary
2017English

The Cost-Effectiveness of CT Colonography in Screening for Colorectal Neoplasia

American Journal of Gastroenterology
HepatologyGastroenterology
2007English

Hormonal Contraception Among Electronic Cigarette Users and Cardiovascular Risk: A Systematic Review

Contraception
GynecologyReproductive MedicineObstetrics
2016English

Challenges in Evaluating the Cost-Effectiveness of Statins

Journal of Managed Care Pharmacy
2004English

A Cost-Effectiveness Analysis of First Trimester Non-Invasive Prenatal Screening for Fetal Trisomies in the United States

PLoS ONE
Multidisciplinary
2015English

Does Hormonal Contraception During Molar Pregnancy Follow-Up Influence the Risk and Clinical Aggressiveness of Gestational Trophoblastic Neoplasia After Controlling for Risk Factors?

Gynecologic Oncology
GynecologyOncologyObstetrics
2017English

The Effectiveness of First Trimester Combined Screening on Reducing the Rate of Invasive Genetic Procedures in a City Based Population of Hungary 2010-2013

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy